Company Intelligence
PathAI
PathAI provides enterprise-grade artificial intelligence solutions, delivering specialized PathAI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Boston, United States
- Website
- www.pathai.com
- Founded
- 2016
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
PathAI is a Healthcare AI company based in Boston, United States, founded in 2016.
Boston digital pathology company applying AI to tissue analysis, with a announced Roche merger agreement pending close.
Verified founder profile on Brel: Andrew Beck.
What it does
Through the deployment of PathAI Platform, PathAI provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
PathAI Platform
Why It Matters
PathAI provides enterprise-grade artificial intelligence solutions, delivering specialized PathAI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
PathAI — Digital Pathology
Explore PathAI — Digital Pathology by PathAI. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
PathAI
Industry
Industries served
- Digital Pathology
Products
Capabilities
PathAI's core AI capability is computer vision applied to whole-slide images: convolutional and related deep-learning architectures trained to recognize patterns in stained…
Features
AI-powered digital pathology platform for analyzing histopathology slides, supporting diagnostic workflows, biomarker assessment, and pharmaceutical research use cases.
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Acquisitions
- May 7, 2026: Roche announced a definitive merger agreement to acquire PathAI, with $750 million upfront consideration; the transaction had not closed as of this review.
Frequently Asked Questions
What does PathAI do?
PathAI specializes in artificial intelligence, developing PathAI Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is PathAI based and when was it founded?
PathAI is based in United States and was founded in 2016.
What are the main products offered by PathAI?
The flagship platform from PathAI is PathAI Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of PathAI?
PathAI primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.